Environmental enrichment, sexual dimorphism, and brain size in sticklebacks

Evidence for phenotypic plasticity in brain size and the size of different brain parts is widespread, but experimental investigations into this effect remain scarce and are usually conducted using individuals from a single population. As the costs and benefits of plasticity may differ among populations, the extent of brain plasticity may also differ from one population to another. In a common garden experiment conducted with three-spined sticklebacks (Gasterosteus aculeatus) originating from four different populations, we investigated whether environmental enrichment (aquaria provided with structural complexity) caused an increase in the brain size or size of different brain parts compared to controls (bare aquaria). We found no evidence for a positive effect of environmental enrichment on brain size or size of different brain parts in either of the sexes in any of the populations. However, in all populations, males had larger brains than females, and the degree of sexual size dimorphism (SSD) in relative brain size ranged from 5.1 to 11.6% across the populations. Evidence was also found for genetically based differences in relative brain size among populations, as well as for plasticity in the size of different brain parts, as evidenced by consistent size differences among replicate blocks that differed in their temperature.Peer reviewe

The concept of sustainability in smart city definitions

Smart cities have emerged as a possible solution to sustainability problems stemming from rapid urbanization. They are considered imperative for a sustainable future. Despite their recent popularity, the literature reveals the lack of conceptual clarity around the term of smart city, due to the plethora of existing definitions. This comprehensive literature review has identified 31 smart city definitions recovered by non-technology focused literature. The definitions are assessed according to the dimensions of sustainability that they consider, environmental, economic or social, and the priority in which they accord the concept of sustainability. The study reveals that not all approaches to smart city incorporate the notion of sustainability in the same way. Additionally, themes emerge according to the dimensions these definitions consider as well as according to whether they derive from the industry or not. Some definitions offer a more balanced holistic view while others appear to be more focused on different smart city goals or variant ways to achieve them. The findings of this study contribute to knowledge and practice by aiding conceptual clarity and, in particular, by drawing attention to underlying assumptions about the role of sustainability in smart city development.sustainability in smart city development

The Contrasting Approach of Contractors Operating in International Markets to the Management of Well-being

Organisational culture is affected by the regional, national and social contexts, which in turn affect Occupational Health, Safety and Wellbeing (OHSW) policies and practices. Health and Safety (H&S) outcomes vary between different countries. Less is known as to how contractors operating in international markets respond to and manage OHSW. This paper examines the extent of standardisation and contextualisation within such practices, and the tensions between them. The focus is upon contractors working in different countries and their clients. It is found that contractors emphasise occupational health and more recently well-being policies with the expectation that this will induce positive H&S outcomes. There is less attention given to highlevel standardised templates, while more attention is given to standardising local practices regardless of context. International contractors give autonomy to local management as part of a transactional approach. There are weak systems between the firm and projects. The findings show wide variance in policies and practices between firms in the supply chain and more significantly within the same firms, pointing to the need for a degree of international standardisation for H&S practices within which contextual variance is accommodated. This will also help the development of more transformational business models to support sustainable OHSW

A Novel Multimodal Biometric Authentication System Using Machine Learning and Blockchain

Secure user authentication has become an important issue in modern society as in many consumer applications, especially financial transactions, it is extremely important to prove the identity of the user. In this context, biometric authentication methods that rely on physical and behavioural characteristics have been proposed as an alternative for convolutional systems that rely on simple passwords, Personal Identification Number or tokens. However, in real-world applications, authentication systems that involve a single biometric faced many issues, especially lack accuracy and noisy data, which boost the research community to create multibiometric systems that involve a variety of biometrics. Those systems provide better performance and higher accuracy compared to other authentication methods. However, most of them are inconvenient and requires complex interactions from the user. Thus, in this paper, we present a multimodal authentication system that relies on machine learning and blockchain, intending to provide a more reliable, transparent, and convenient authentication mechanism. The proposed system combines tow important biometrics: fingerprint and face with age, and gender features. The supervised learning algorithm Decision Tree has been used to combine the results of the biometrics verification process and produce a confidence level related to the user. The initial experimental results show the efficiency and robustness of the proposed systems

Does Diabetes Accelerate the Progression of Aortic Stenosis through Enhanced Inflammatory Response within Aortic valves?

Diabetes predisposes to aortic stenosis (AS). We aimed to investigate if diabetes affects the expression of selected coagulation proteins and inflammatory markers in AS valves. Twenty patients with severe AS and concomitant type 2 diabetes mellitus (DM) and 40 well-matched patients without DM scheduled for valve replacement were recruited. Valvular tissue factor (TF), TF pathway inhibitor (TFPI), prothrombin, C-reactive protein (CRP) expression were evaluated by immunostaining and TF, prothrombin, and CRP transcripts were analyzed by real-time PCR. DM patients had elevated plasma CRP (9.2 [0.74–51.9] mg/l vs. 4.7 [0.59–23.14] mg/l, p = 0.009) and TF (293.06 [192.32–386.12] pg/ml vs. 140 [104.17–177.76] pg/ml, p = 0.003) compared to non-DM patients. In DM group, TF−, TFPI−, and prothrombin expression within valves was not related to demographics, body mass index, and concomitant diseases, whereas increased expression related to DM was found for CRP on both protein (2.87 [0.5–9]% vs. 0.94 [0–4]%, p = 0.01) and transcript levels (1.3 ± 0.61 vs. 0.22 ± 0.43, p = 0.009). CRP-positive areas were positively correlated with mRNA TF (r = 0.84, p = 0.036). Diabetes mellitus is associated with enhanced inflammation within AS valves, measured by CRP expression, which may contribute to faster AS progression

Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover

Cutaneous T-cell lymphomas (CTCL) are characterized by the presence of chronically inflamed skin lesions containing malignant T cells. Early disease presents as limited skin patches or plaques and exhibits an indolent behavior. For many patients, the disease never progresses beyond this stage, but in approximately one third of patients, the disease becomes progressive, and the skin lesions start to expand and evolve. Eventually, overt tumors develop and the malignant T cells may disseminate to the blood, lymph nodes, bone marrow, and visceral organs, often with a fatal outcome. The transition from early indolent to progressive and advanced disease is accompanied by a significant shift in the nature of the tumor-associated inflammation. This shift does not appear to be an epiphenomenon but rather a critical step in disease progression. Emerging evidence supports that the malignant T cells take control of the inflammatory environment, suppressing cellular immunity and anti-tumor responses while promoting a chronic inflammatory milieu that fuels their own expansion. Here, we review the inflammatory changes associated with disease progression in CTCL and point to their wider relevance in other cancer contexts. We further define the term "malignant inflammation" as a pro-tumorigenic inflammatory environment orchestrated by the tumor cells and discuss some of the mechanisms driving the development of malignant inflammation in CTCL

2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling

Neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS), affect millions of people every year and so far, there are no therapeutic cures available. Even though animal and histological models have been of great aid in understanding disease mechanisms and identifying possible therapeutic strategies, in order to find disease-modifying solutions there is still a critical need for systems that can provide more predictive and physiologically relevant results. One possible avenue is the development of patient-derived models, e.g. by reprogramming patient somatic cells into human induced pluripotent stem cells (hiPSCs), which can then be differentiated into any cell type for modelling. These systems contain key genetic information from the donors, and therefore have enormous potential as tools in the investigation of pathological mechanisms underlying disease phenotype, and progression, as well as in drug testing platforms. hiPSCs have been widely cultured in 2D systems, but in order to mimic human brain complexity, 3D models have been proposed as a more advanced alternative. This review will focus on the use of patient-derived hiPSCs to model AD, PD, HD and ALS. In brief, we will cover the available stem cells, types of 2D and 3D culture systems, existing models for neurodegenerative diseases, obstacles to model these diseases in vitro, and current perspectives in the field